SEC Form 4 · accession 0001209191-16-127171
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roberto Pedro Rosenkranz
Director
Period of report
Jun 8, 2016
Accepted (ET)
Jun 10, 2016 · 6:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.05 | Jun 8, 2016 | A | 12,000 | A | — | Jun 8, 2026 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The shares subject to the option vest and become exercisable quarterly over one year measured from June 8, 2016.